ArticleFrontiers in pharmacology2024

Empagliflozin improves pressure-overload-induced cardiac hypertrophy by inhibiting the canonical Wnt/β-catenin signaling pathway.

Xun Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.